Labcorp Holdings Inc. (LH) Valuation
Historical valuation analysis based on 500 data points (2024-08-30 to 2026-08-28)
Labcorp is one of the nation's two largest independent clinical laboratories, with roughly 20% of the independent lab market. The company operates approximately 2,000 patient-service centers, offer...
Labcorp Holdings Inc. (LH) currently trades at a P/E ratio of 29.51 (historical range: 22.05–49.76, median: 29.28), placing it at the 51th percentile — near its historical average, P/S ratio of 1.96 (range: 1.44–2.13, 92th percentile — expensive relative to its history), EV/EBITDA of 85.70 (range: 18.44–102.10, 87th percentile).
Over the historical period (2024-08-30 to 2026-08-28), Labcorp Holdings Inc.'s P/E ratio has contracted by 36% over the observed period (from an average of 40.5 to 26.0).
Labcorp Holdings Inc. appears overvalued relative to its own historical valuation range, trading at elevated multiples across most metrics.
Historical Valuation Metrics
| Metric | Current | Min | Median | Max | Percentile | Assessment |
|---|---|---|---|---|---|---|
| P/E Ratio | 29.51 | 22.05 | 29.28 | 49.76 | 51th | near its historical average |
| P/S Ratio | 1.96 | 1.44 | 1.63 | 2.13 | 92th | expensive relative to its history |
| EV/EBITDA | 85.70 | 18.44 | 34.59 | 102.10 | 87th | expensive relative to its history |
| FCF Yield | 0.00 | 0.00 | 0.02 | 0.06 | 1th | expensive relative to its history |